All patients (N = 37) | ΔAIx ≥3.3% (N = 19) | ΔAIx < 3.3% (N = 18) | P value | |
---|---|---|---|---|
Age (years) | 63.3 ± 9.4 | 61.7 ± 10.4 | 65.0 ± 8.1 | 0.288 |
Male | 23 (62) | 15 (79) | 8 (44) | 0.045 |
Height (cm) | 160.8 ± 8.9 | 162.6 ± 8.4 | 158.9 ± 9.3 | 0.213 |
Weight (kg) | 65.7 ± 12.4 | 69.2 ± 13.1 | 62.1 ± 10.8 | 0.081 |
Body mass index (kg/m2) | 25.27 ± 3.30 | 25.98 ± 3.17 | 24.51 ± 3.36 | 0.180 |
Smoker | 9 (24) | 5 (26) | 4 (22) | 0.124 |
Hypertension | 26 (70) | 13 (68) | 13 (72) | 1.000 |
Diabetes mellitus | 8 (22) | 3 (16) | 5 (28) | 0.447 |
Hyperlipidemia | 33 (89) | 18 (95) | 15 (83) | 0.340 |
Chronic kidney disease | 19 (51) | 8 (42) | 11 (61) | 0.330 |
Prior myocardial infarction | 11 (30) | 5 (26) | 6 (33) | 0.728 |
Coronary artery disease | 27 (73) | 15 (79) | 12 (67) | 0.476 |
CAG findings | 0.620 | |||
1 vessel disease | 13 (48) | 6 (40) | 7 (58) | 0.313* |
2 vessel disease | 9 (33) | 6 (40) | 3 (25) | |
3 vessel disease | 5 (19) | 3 (20) | 2 (17) | |
PCI | 25 (68) | 13 (68) | 12 (67) | 1.000 |
Medications | ||||
Calcium channel blockers | 16 (43) | 10 (53) | 6 (33) | 0.325 |
RAS inhibitors | 18 (49) | 9 (47) | 9 (50) | 1.000 |
Beta-blockers | 22 (60) | 13 (68) | 9 (50) | 0.325 |
Nitrate | 8 (22) | 4 (21) | 4 (22) | 1.000 |
Statins | 31 (84) | 18 (95) | 13 (72) | 0.090 |